Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Headquarters:
Taipei, T'ai-pei, Taiwan
Total Funding:
$10M
Founded Date:
2015-01-01
Employee Number:
11-50
Last Funding Type:
Series B
Investors Number:
4
Last Funding Date:
2020-02-26
Technology:
diagnostics
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
Biotechnology, Health Care, Life Science